Study shows the power of electroencephalography and machine learning to help predict response to psychotherapy (or lack thereof) in patients with PTSD

By SharpBrains | May 2, 2023

A fas­ci­nat­ing study just pub­lished in Nature Men­tal Health aimed at help­ing pre­dict the out­comes of psy­chother­a­py for patients with Post-Trau­­mat­ic Stress Dis­or­der (PTSD) using Machine Learn­ing (ML) and elec­troen­cephalog­ra­phy (EEG) data. PTSD is a men­tal health con­di­tion trig­gered by expe­ri­enc­ing or wit­ness­ing a trau­mat­ic event; two evi­­dence-based treatments–Prolonged Expo­sure (PE) and Cog­ni­tive Pro­cess­ing Ther­a­py (CPT)–are…

Read More

Precision psychiatry pioneer Alto Neuroscience raises $35M to advance digital biomarker-to-treatment platform

By SharpBrains | November 7, 2022

Alto Neu­ro­science Rais­es $35M Series B Financ­ing (Fins­Mes): Alto Neu­ro­science, a Los Altos, CA-based neu­ro-tech com­pa­ny which spe­cial­izes in pre­ci­sion psy­chi­a­try, rais­es $35M Series B Financ­ing … The com­pa­ny intends to use the funds to advance lead can­di­dates into Phase 2b stud­ies in major depres­sive dis­or­der … Pro­ceeds from the financ­ing will also be used…

Read More